Quantum Cyber N.V. Boosts Executive Ownership to Drive Long‑Term ValueQuantum Cyber N.V. boosts long‑term shareholder value with new executive equity plans, aligning incentives through option grants and 18‑month vesting.QUANTUM CYBER NV Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 06/08/2026, 15:27 2 minutes to read
Quantum Cyber NV: Stable 8 EUR Stock, Negative P/E, Driving Global Molecular Genetic DiagnosticsQuantum Cyber NV’s stable €8 share price and negative P/E highlight its biotech focus on rapid, molecular‑genetic diagnostics that aim to transform global patient care.QUANTUM CYBER NV Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 14/07/2026, 17:37 2 minutes to read
Quantum Cyber Secures Exclusive Quantum Antenna License, Powering Jam‑Resistant UAV DefenseQuantum Cyber secures exclusive license to Project LightShift’s quantum photonic array, enabling jam‑resistant UAVs for defense and commercial markets.QUANTUM CYBER NV Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 17/06/2026, 13:42 3 minutes to read